Medical Marijuana On-Demand Platform Eaze Inhales $13M In Funding

No matter your politics on the matter, weed is green. On-demand weed platform Eaze has just scored $13 million in Series B funding, thanks to Fresh VC, Doll Capital Management (DCM) and Tusk Ventures. Eaze has now raised a total of $25 million.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Considered to be the “Uber for cannabis,” Eaze has grown after its launch in July 2014, delivering to more than 200,000 people in 100 Californian cities. The data-driven platform allows medical marijuana patients to place an order on the double and, in certain states, become a card-carrying patient in 10 minutes or less.

    The new funding, according to the business, is going to go towards hiring measures, moving into more markets and developing a way to help patients to find the weed strains to best fit them.

    Eaze, however, isn’t the only business in the space. There’s Meadow, GreenRush, Nugg and SpeedWeed, to name a few. And so, that funding that Eaze landed will also go toward making a name for itself in its home state of California, as well as other states that are moving into legalization of the substance.

    The upcoming election could make a dent in the industry.

    “Platforms like Eaze that are setting a new standard for accessibility, safety and professionalism are best positioned to educate and service the future market,” Eaze CEO Keith McCarty said in a statement.

    Advertisement: Scroll to Continue